{"database": "openregs", "table": "documents", "rows": [["FDA-2011-D-0611-0055", "FDA", "FDA-2011-D-0611", "Biosimilars: Additional Questions and Answers Regarding Implementation of the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability", "Notice", "Notice of Availability", "2015-05-13T04:00:00Z", 2015, 5, "2015-05-13T04:00:00Z", "2015-07-14T03:59:59Z", "2015-07-14T01:30:24Z", "2015-11528", 0, 0, "0900006481addda4"]], "columns": ["id", "agency_id", "docket_id", "title", "document_type", "subtype", "posted_date", "posted_year", "posted_month", "comment_start_date", "comment_end_date", "last_modified", "fr_doc_num", "open_for_comment", "withdrawn", "object_id"], "primary_keys": ["id"], "primary_key_values": ["FDA-2011-D-0611-0055"], "units": {}, "query_ms": 9.820088045671582, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}